Merck & Co., Inc.
Close on Nov 2, 2026Market cap $366.03BP/E 118.7Yield 2.21%
Merck Pharmaceutical Sales by Year
Pharmaceutical Sales — Asia Pacific (other than China and Japan) share of Pharmaceutical revenue (%) (%)
Merck Pharmaceutical Sales: 4.0% in FY2025, down 0.3 pts from a year earlier.
Where the FY2025 figure comes from
“Asia Pacific (ex-China & Japan) | || % Pharmaceutical Sales | 4.0 | % | 4.3 | % | 4.1 | % | 3.9 | % | 4.3 | % | 4.1 | % | 3.8 | % | 4.0 | % | 4.0 | %”
Source: Form 8-K (tm2621496d1_ex99-1.htm, filed 2026-08-04) ↗
Reported in Form 8-K Supplemental Table 3c / 3b (Pharmaceutical Geographic Sales).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Pharmaceutical Sales — Asia Pacific (other than China and Japan) share of Pharmaceutical revenue (%) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4.0% | -0.3 pts | Form 8-K (tm2621496d1_ex99-1.htm, filed 2026-08-04) ↗ |
| FY2024 | Dec 31, 2024 | 4.3% | -0.7 pts | Form 8-K (tm264564d1_ex99-1.htm, filed 2026-02-03) ↗ |
| FY2023 | Dec 31, 2023 | 5.0% | -0.8 pts | Form 8-K (tm255059d1_ex99-1.htm, filed 2025-02-04) ↗ |
| FY2022 | Dec 31, 2022 | 5.8% | +1.6 pts | Form 8-K (tm244517d1_ex99-1.htm, filed 2024-02-01) ↗ |
| FY2021 | Dec 31, 2021 | 4.2% | -0.2 pts | Form 8-K (tm235007d1_ex99-1.htm, filed 2023-02-02) ↗ |
| FY2020 | Dec 31, 2020 | 4.4% | -1.6 pts | Form 8-K (tm2131077d1_ex99-1.htm, filed 2021-10-28) ↗ |
| FY2019 | Dec 31, 2019 | 6.0% | – | Form 8-K (tm2032785d1_ex99-1.htm, filed 2020-10-27) ↗ |
Cite this data
StockData. (2026). Merck Pharmaceutical Sales (%), annual FY2019–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/pharma-geo-asiapacific-excnjp-share
See every metric in the Merck KPI table. Data updated Oct 26, 2026.